STENOCARE A/S, founded in 2017, supplies prescription-based medical cannabis to patients in Denmark and internationally. It was the first company to receive permission from the Danish Medicines Agency to import, distribute, cultivate, and produce medical cannabis. Today, STENOCARE sources its products from a selection of high-quality international suppliers that comply with the strict European Good Manufacturing Practices (EU-GMP). STENOCARE has developed a unique patented medical cannabis oil product, ASTRUM, which provides improved bioavailability of active ingredients for patients. The company has strategically invested in assets to operate within the highly regulated pharmaceutical industry, with products approved for sale in multiple countries. Stenocare is a public company that is traded on Nasdaq First North Copenhagen.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Lejrvej 9, Kirke Værløse,capital Region Of Denmark 3500,denmark
- Phone
- 45 31 77 00 60
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- stenocare.com
- HQ
- Kirke Værløse, Capital Region of Denmark
Stenocare A/s Questions
Stenocare A/S's helpline number is 45 31 77 00 60
Stenocare A/S's website is stenocare.com
Stenocare A/S's LinkedIn profile is https://dk.linkedin.com/company/stenocare
Stenocare A/S has
7 employees.
View email and phone details for 7
employees at Stenocare A/S.
Stenocare A/S's industry is
Pharmaceutical Manufacturing
Stenocare A/S's top competitors are
Cansativa Gmbh,
Canngros Aps,
Scanleaf,
Demecan,
Qntm Labs®,
Kapital Klubben,
Cantourage,
Synbiotic Se,
Valeos Pharma A/s,
Dancann Pharma A/s.
Stenocare A/S's categories are Pharmaceutical Manufacturing
Stenocare A/S's founding year is 2017
